NEW YORK (AP) — A record low 54 major league players were given permission to use medication for attention deficit hyperactivity disorder, down from 61 last year and 119 in 2013.
The total was revealed Monday in the annual report of Thomas M. Martin, the independent program administrator of the drug program for Major League Baseball and the players' association. The most-used medications to treat ADHD are Adderall, Ritalin and Vyvanse.
There were 11,700 drug tests collected in the year ending with the 2025 World Series, just below the record 11,783 in the year ending with the 2023 World Series. This year's total included 9,400 urine samples and 2,300 blood samples used to detect Human Growth Hormone.
Just two tests were positive and resulted in discipline among players on 40-man rosters: Atlanta Braves outfielder Jurickson Profar was suspended for 80 games on March 31 for a positive test for Chorionic Gonadotrophin, a hormone that helps in the production of testosterone; and Philadelphia Phillies closer José Alvarado was banned for 80 games on May 18 for a positive test for external testosterone.
Profar said he didn't knowingly take the banned substance. Phillies president of baseball operations Dave Dombrowski said Alvarado's positive test was caused by a weight loss drug the pitcher took during the offseason.
In addition to the 54 Therapeutic Use Exemptions for ADHD, there was one for hypertension, one for sleep disorder and one for hormone function.
AP MLB: https://apnews.com/MLB
Copyright 2025 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed without permission.
Please purchase a Premium Subscription to continue reading.
To continue, please log in, or sign up for a new account.
We offer one free story view per month. If you register for an account, you will get two additional story views. After those three total views, we ask that you support us with a subscription.
A subscription to our digital content is so much more than just access to our valuable content. It means you’re helping to support a local community institution that has, from its very start, supported the betterment of our society. Thank you very much!
Only subscribers can view and post comments on articles.
Already a subscriber? Login Here
We're excited to announce our India Community Travel in Spring 2026! Join this virtual Zoom … Read moreTravel to India Information Session (Online)
“A dazzling delight for all ages” Read moreRodger's & Hammerstein's Cinderella
Join us for Bay Area Youth Ballet's magical holiday tradition as The Nutcracker comes to lif… Read moreThe Nutcracker Presented By Bay Area Youth Ballet
Mike Harris said:
Dirk van Ulden said:
Success! An email has been sent to with a link to confirm list signup.
Error! There was an error processing your request.
Sorry, an error occurred.
Already Subscribed!
Cancel anytime
Thank you .
Your account has been registered, and you are now logged in.
Check your email for details.
Submitting this form below will send a message to your email with a link to change your password.
An email message containing instructions on how to reset your password has been sent to the email address listed on your account.
No promotional rates found.
Secure & Encrypted
Thank you.
Your gift purchase was successful! Your purchase was successful, and you are now logged in.
| Rate: | |
| Begins: | |
| Transaction ID: |
A receipt was sent to your email.
(0) comments
Welcome to the discussion.
Log In
Keep the discussion civilized. Absolutely NO personal attacks or insults directed toward writers, nor others who make comments.
Keep it clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
Don't threaten. Threats of harming another person will not be tolerated.
Be truthful. Don't knowingly lie about anyone or anything.
Be proactive. Use the 'Report' link on each comment to let us know of abusive posts.
PLEASE TURN OFF YOUR CAPS LOCK.
Anyone violating these rules will be issued a warning. After the warning, comment privileges can be revoked.